I would have preferred he used the opportunity to

I would have preferred he used the opportunity to "suck up" to the FDA. He could have said "the FDA has a very important and difficult job made much harder with Covid but they are doing an amazing job to keep us safe and we are working closely with the FDA."

I wish since Neal butchered our name NP could have said Leronlimab as many times as possible. LL this or LL that. Get the name out as often as possible.

A clear mention that we are currently enrolling our S/C trials and info is available at CytoDyn.com would have been great.

All ideas for tomorrows interview. I hope we have more CNBC would be a great followup. Sara Eisen has mentioned LL and tweeted about LL.